Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite
Selenoprotein P (SELENOP) is an established biomarker of selenium (Se) status. Serum SELENOP becomes saturated with increasing Se intake, reaching maximal concentrations of 5–7 mg SELENOP/L at intakes of ca. 100–150 µg Se/d. A biomarker for higher Se intake is missing. We hypothesized that SELENOP m...
Main Authors: | Ola Brodin, Julian Hackler, Sougat Misra, Sebastian Wendt, Qian Sun, Elena Laaf, Christian Stoppe, Mikael Björnstedt, Lutz Schomburg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/4/1067 |
Similar Items
-
Selenium and Selenoproteins in Immune Mediated Thyroid Disorders
by: Liliana R. Santos, et al.
Published: (2018-10-01) -
Dietary Selenium and Human Health
by: Lutz Schomburg
Published: (2016-12-01) -
Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death
by: Lutz Schomburg, et al.
Published: (2019-08-01) -
Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker
by: Raban Arved Heller, et al.
Published: (2021-01-01) -
Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
by: Qian Sun, et al.
Published: (2020-06-01)